{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:13:12Z","timestamp":1780805592051,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":728,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.14338\/ijpt-21-00011.1","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T22:02:14Z","timestamp":1625781734000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma"],"prefix":"10.1016","volume":"8","author":[{"given":"James E.","family":"Bates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Terezakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avani D.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchi","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond B.","family":"Mailhot Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford S.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14338\/IJPT-21-00011.1_bib1","doi-asserted-by":"crossref","first-page":"725219","DOI":"10.1155\/2011\/725219","article-title":"Incidence patterns and outcomes for Hodgkin lymphoma patients in the United States","volume":"2011","author":"Shenoy","year":"2011","journal-title":"Adv Hematol"},{"key":"10.14338\/IJPT-21-00011.1_bib2","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib3","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/cncr.31519","article-title":"Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: a report from the Children's Oncology Group","volume":"124","author":"Keller","year":"2018","journal-title":"Cancer"},{"key":"10.14338\/IJPT-21-00011.1_bib4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"New Engl J Med"},{"key":"10.14338\/IJPT-21-00011.1_bib5","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib6","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1200\/JCO.2011.38.5807","article-title":"Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial","volume":"30","author":"von Tresckow","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/pbc.24968","article-title":"Patterns of failure after involved field radiation therapy for pediatric and young adult Hodgkin lymphoma","volume":"61","author":"Huynh-Le","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.14338\/IJPT-21-00011.1_bib9","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin's lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.14338\/IJPT-21-00011.1_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.14338\/IJPT-21-00011.1_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/oxfordjournals.annonc.a059221","article-title":"Lung function impairment in long-term survivors of Hodgkin's disease","volume":"6","author":"Lund","year":"1995","journal-title":"Ann Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib12","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.2016.71.6902","article-title":"Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: role of chemotherapy","volume":"35","author":"Teepen","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib13","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"10.14338\/IJPT-21-00011.1_bib14","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/annonc\/mdx287","article-title":"Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma","volume":"28","author":"Hoppe","year":"2017","journal-title":"Ann Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2014.10.042","article-title":"Patterns of relapse from a phase 3 study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group","volume":"92","author":"Dharmarajan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00011.1_bib16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ijrobp.2018.01.002","article-title":"Patterns of involved-field radiation therapy protocol deviations in pediatric versus adolescent and young adults with Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031","volume":"100","author":"Parzuchowski","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00011.1_bib17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1200\/JCO.18.01764","article-title":"Therapy-related cardiac risk in childhood cancer survivors: an analysis of the Childhood Cancer Survivor Study","volume":"37","author":"Bates","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2015.02.010","article-title":"Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma","volume":"92","author":"Pinnix","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00011.1_bib19","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/cncr.29841","article-title":"Therapeutic radiation and the potential risk of second malignancies","volume":"122","author":"Kamran","year":"2016","journal-title":"Cancer"},{"key":"10.14338\/IJPT-21-00011.1_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13014-019-1360-7","article-title":"Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease","volume":"14","author":"Lautenschlaeger","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-018-1066-2","article-title":"Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation: a planning comparison of deep inspiration breath hold intensity modulation radiotherapy and intensity modulated proton therapy","volume":"13","author":"Baues","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2017.07.033","article-title":"Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: the impact of proton therapy and\/or deep inspiration breath hold","volume":"125","author":"Rechner","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.prro.2019.01.006","article-title":"Clinical intensity modulated proton therapy for hodgkin lymphoma: which patients benefit the most?","volume":"9","author":"Ntentas","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.14338\/IJPT-21-00011.1_bib24","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/pbc.26044","article-title":"Proton therapy for pediatric Hodgkin lymphoma","volume":"63","author":"Wray","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.14338\/IJPT-21-00011.1_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clml.2015.11.006","article-title":"Trends in use of radiation therapy for hodgkin lymphoma from 2000 to 2012 on the basis of the National Cancer Data Base","volume":"16","author":"Goyal","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/8\/3\/21\/3004278\/i2331-5180-8-3-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/8\/3\/21\/3004278\/i2331-5180-8-3-21.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:34:13Z","timestamp":1762421653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518023002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2331518023002172"],"URL":"https:\/\/doi.org\/10.14338\/ijpt-21-00011.1","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14338\/IJPT-21-00011.1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 \u00a9 2021 THE AUTHORS. Published by Elsevier BV on behalf of the Particle Therapy Co-operative Group. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}